NCT06288815

Brief Summary

The goal of this study is to compared efficacy of oral fluid and intravenous fluid after primary unilateral total knee arthroplasty. The main question it aims to answer is: Does oral fluid replacement after primary unilateral total knee arthroplasty provide a patient recover faster than intravenous fluids replacement?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

March 4, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

February 25, 2024

Last Update Submit

March 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to stand and walk

    Stand and walk with walker

    Postoperative day 1

Secondary Outcomes (8)

  • Time up and go

    24 and 48 hours

  • Incidence of oliguria

    Postoperative day 1,2

  • Incidence of nausea/vomiting

    Postoperative day 1,2

  • Urine specific gravity

    Postoperative day 1

  • the levels of certain electrolytes

    Postoperative day 1,2

  • +3 more secondary outcomes

Study Arms (2)

Oral fluid

EXPERIMENTAL

* NPO (8hr for food, 2hr for water) * Intraoperative IV fluid at least 1 liter * Post operative (Off IV fluid, allow oral fluid as protocol at least 24hr)

Dietary Supplement: Oral fluid

IV fluid

ACTIVE COMPARATOR

* NPO (8hr for food, 2hr for water) * Intraoperative IV fluid at least 1 liter * Post operative (IV fluid as protocol at least 24hr, allow oral fluid as usual)

Dietary Supplement: IV fluid

Interventions

Oral fluidDIETARY_SUPPLEMENT

Postoperation * Off IV fluid immediately postoperative * Allow patients drink oral fluid as protocol for 24hr

Oral fluid
IV fluidDIETARY_SUPPLEMENT

Postoperation * IV fluid replacement as protocol for 24hr * Allow patients drink oral fluid as usual

IV fluid

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40-85 years old
  • ASA I, II
  • Primary osteoarthritis

You may not qualify if:

  • Diuretics use
  • Morbid obesity
  • Previous knee surgery
  • Cannot undergo spinal anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thammasat University

Khlong Luang, Changwat Pathum Thani, 12120, Thailand

RECRUITING

Related Publications (1)

  • Jennings JM, Mejia M, Williams MA, Johnson RM, Yang CC, Dennis DA. The James A. Rand Young Investigator's Award: Traditional Intravenous Fluid vs. Oral Fluid Administration in Primary Total Knee Arthroplasty: A Randomized Trial. J Arthroplasty. 2020 Jun;35(6S):S3-S9. doi: 10.1016/j.arth.2020.01.029. Epub 2020 Jan 22.

    PMID: 32037213BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Fluid Therapy

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Central Study Contacts

Yot Tanariyakul, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

February 25, 2024

First Posted

March 1, 2024

Study Start

January 10, 2024

Primary Completion

December 1, 2024

Study Completion

June 1, 2025

Last Updated

March 4, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations